10 Considerations in a Life Science License

Posted on September 5, 2011 by admin| Leave a comment

When I collaborated with Linda Pullan, Ph.D. (formerly with Amgen, Kosan and Astra Zeneca) on a drug development and license agreement, I thought she gave some terrific advice and so I asked her to put together this list of her top 10 considerations.


Click here for downloadable PDF: Top 10 Life Sciences

This entry was posted in Licensing Provisions, TechTransaction. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>